First Horizon Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

First Horizon Advisors’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-870	Closed	-$37K	–	1463
2015 Q3	$37K	Sell	870 -250	-22%	-$10.6K	0.01%	607
2015 Q2	$46K	Buy	1,120 +28	+3%	+$1.18K	0.01%	570
2015 Q1	$42K	Buy	1,092 +48	+5%	+$1.85K	0.01%	604
2014 Q4	$35K	Buy	1,044 +309	+42%	+$10.9K	0.01%	654
2014 Q3	$25K	Buy	735 +85	+13%	+$2.91K	﹤0.01%	757
2014 Q2	$20K	Buy	650 +47	+8%	+$1.61K	﹤0.01%	833
2014 Q1	$22K	Hold	603	–	–	﹤0.01%	749
2013 Q4	$20K	Buy	+603	New	+$19K	﹤0.01%	745

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

First Horizon Advisors's WX Position: Q4 2015 in Review

First Horizon Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 870 shares — an estimated $37K sold.

First Horizon Advisors first reported a position in WX in Q4 2013 and held it in 8 quarters. The position peaked at $46K in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

First Horizon Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
First Horizon Advisors sold 870 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $37K.
First Horizon Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 8 quarters.
First Horizon Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $46K in Q2 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on First Horizon Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.